SuperworthPacific Biosciences of California shares outstanding PACB
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 310.7M
- On a year earlier
- +3.5%
- more shares
Pacific Biosciences of California had 310.7M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 3.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 301.9M | +2% |
| FY2024 | 296.9M | +11% |
| FY2023 | 267.1M | +18% |
| FY2022 | 226.2M | +2% |
| FY2021 | 220.7M | +13% |
| FY2020 | 195.8M | +28% |
| FY2019 | 153.1M | +3% |
| FY2018 | 149.3M | +28% |
| FY2017 | 116.3M | +25% |
| FY2016 | 92.7M | +18% |
| FY2015 | 78.3M | +8% |
| FY2014 | 72.7M | +10% |
| FY2013 | 66.2M | +18% |
| FY2012 | 56.2M | +2% |
| FY2011 | 55.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 310.7M | +3% | |
| Q1 FY26 | 305.8M | +3% | |
| Q4 FY25 | 301.9M | +2% | |
| Q3 FY25 | 300.8M | +10% | |
| Q2 FY25 | 300.2M | +10% | |
| Q1 FY25 | 296.9M | +10% | |
| Q4 FY24 | 296.9M | +11% | |
| Q3 FY24 | 272.9M | +7% | |
| Q2 FY24 | 272.4M | +9% | |
| Q1 FY24 | 269.6M | +11% | |
| Q4 FY23 | 267.1M | +18% | |
| Q3 FY23 | 255M | +13% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Pacific Biosciences of California
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.